How should I evaluate and manage a 45-year-old man with a three-month history of cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of a 45-Year-Old Man with 3-Month Chronic Cough

Initial Assessment

Begin with a focused history targeting ACE inhibitor use, smoking status, and red-flag symptoms, followed immediately by chest radiograph and spirometry. 1, 2

Critical Historical Elements

  • Medication review: Discontinue any ACE inhibitor immediately regardless of temporal relationship—cough typically resolves within days to 2 weeks (median 26 days) 3, 4
  • Smoking history: If the patient smokes, counsel on cessation as the primary intervention; most smoking-related coughs resolve within 4 weeks 3, 1
  • Red-flag symptoms requiring urgent investigation include:
    • Hemoptysis 3, 1
    • Unintentional weight loss or fever 3, 2
    • Significant dyspnea at rest or night 1, 2
    • Hoarseness or dysphagia 1, 2
    • History of cancer, tuberculosis, or immunosuppression 3
  • Occupational/environmental exposures to irritants or allergens 1, 4

Mandatory Baseline Investigations

  • Chest radiograph to exclude malignancy, infection, structural disease, or heart failure 1, 2, 4
  • Spirometry to detect obstructive airway disease 1, 5
  • Cough severity quantification using validated visual analog scales or quality-of-life questionnaires 1, 2

Systematic Empiric Treatment Algorithm

The three most common causes—upper airway cough syndrome (UACS), asthma, and gastroesophageal reflux disease (GERD)—account for over 90% of chronic cough cases and should be treated sequentially. 3, 1, 2

Step 1: Treat Upper Airway Cough Syndrome (UACS) First

  • UACS is the single most common cause (18.6–81.8% of cases) and should be addressed first 1, 2
  • Initiate a first-generation antihistamine-decongestant combination for 1-2 weeks 2, 4
  • If prominent nasal symptoms exist, add topical intranasal corticosteroids 1
  • Clinical pointers include postnasal drip sensation, throat clearing, nasal discharge, or rhinorrhea 4

Step 2: Evaluate and Treat Asthma if UACS Treatment Fails

  • Asthma accounts for 14.6–41.3% of chronic cough and may present with cough as the sole manifestation 1, 4
  • Normal spirometry does not exclude asthma—proceed with methacholine bronchial provocation testing if spirometry is normal 1, 4
  • Initiate inhaled corticosteroids with or without bronchodilators 3
  • Consider a 2-week trial of oral corticosteroids (30-40 mg prednisone daily); lack of improvement suggests cough is unlikely due to eosinophilic airway inflammation 3, 1
  • Response to bronchodilators may occur within 1 week, but complete resolution can take up to 8 weeks 4

Step 3: Treat GERD if Both UACS and Asthma Treatments Fail

  • GERD causes 4.6–85.4% of chronic cough and frequently occurs without gastrointestinal symptoms 1, 4
  • Initiate intensive acid suppression with proton pump inhibitors plus alginates for a minimum of 3 months 1, 2
  • Add comprehensive dietary modifications and lifestyle changes (not just PPIs alone) 2, 4
  • Be patient: response may take 2 weeks to several months, with some patients requiring 8-12 weeks 4
  • Failure to consider GERD is a frequent cause of therapeutic failure 1

Step 4: Consider Nonasthmatic Eosinophilic Bronchitis (NAEB)

  • NAEB accounts for 6.4–17.2% of cases and presents with normal spirometry and no airway hyperresponsiveness 1, 4
  • Treat with inhaled corticosteroids 3

Critical Management Principles

  • Up to 67% of patients have multiple simultaneous causes—maintain all partially effective treatments and use additive therapy 1, 2
  • Schedule follow-up within 4-6 weeks to reassess response using validated cough severity measures 1, 2, 4
  • Optimize therapy for each diagnosis and check compliance before abandoning a treatment approach 3

Advanced Investigation for Refractory Cases

If empiric treatments for UACS, asthma, and GERD fail after adequate trials:

  • Order high-resolution CT chest to evaluate for bronchiectasis, interstitial lung disease, or occult masses 1, 4
  • Consider 24-hour esophageal pH monitoring if GERD remains suspected despite empiric therapy failure 4
  • Reserve bronchoscopy for suspected foreign body, endobronchial lesions, or sarcoidosis 1, 4
  • Refer to a specialized cough clinic for comprehensive evaluation 1, 2

Management of Truly Refractory Chronic Cough

Only diagnose unexplained/idiopathic cough after completing systematic evaluation and adequate therapeutic trials of all common causes. 1, 4

  • Consider gabapentin starting at 300 mg once daily, escalating to maximum 1,800 mg daily in divided doses 4, 5, 6
  • Speech pathology/cough control therapy is a reasonable alternative 4, 5, 6
  • Low-dose morphine may be considered but carries addiction risk 4, 6

Common Pitfalls to Avoid

  • Never continue ACE inhibitors in any patient with troublesome chronic cough 1, 4
  • Do not proceed to extensive testing before completing adequate empiric treatment trials (4-6 weeks each) 1, 2, 6
  • Do not assume a single cause—sequential and additive therapy is essential given the high frequency of multiple contributing factors 1, 2
  • Do not diagnose idiopathic cough prematurely before systematically addressing UACS, asthma, GERD, and NAEB 1, 4

References

Guideline

Evaluation and Management of Chronic Cough in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Chronic Cough

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluation and Management of Persistent Dry Cough

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Evaluation and management of chronic cough in adults.

Allergy and asthma proceedings, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.